ZEISS showcases advancements in technology
Advancements aim to help doctors maximise clinical efficiency and performance


Colin Kerr
Published: Sunday, September 15, 2019
[caption id="attachment_16606" align="alignleft" width="1024"]
Jim Mazzo (left) and Ludwin Monz at yesterday's ZEISS press briefing [/caption]
ZEISS unveiled a suite of new technologies advancing the digitalisation of eye care and high-resolution imaging, helping doctors maximise clinical efficiency and performance, at the 37th ESCRS Congress in Paris yesterday.
ZEISS introduced the ZEISS EQ Workplace®, the latest addition to the ZEISS Cataract Suite, offering surgeons a digital solution to connect and streamline the refractive cataract workflow.
The ZEISS ARTEVO® 800, the first digital microscope in ophthalmic surgery, recently received CE mark, and includes integrated digital optics for optimised digital visualisation and cloud connectivity to the EQ Workplace, providing surgeons remote access to patient data and images.
Also featured at ESCRS is the ZEISS miLOOP®, a micro-interventional device designed to deliver zero-energy endocapsular lens fragmentation. The miLOOP device has received CE mark and is now available to surgeons in markets outside of the USA.
ZEISS expands its CIRRUS® optical coherence tomography (OCT) portfolio with the launch of its new CIRRUS® 6000, the next generation, ultra-fast 100kHz system.
Speaking to EuroTimes, Jim Mazzo, Global President of Ophthalmic Devices at Carl Zeiss Meditec, said improving outcomes for patients while making practice easier and more efficient for doctors through the latest technology is at the heart of what the company does.

Tags: zeiss
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.